CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Molecular Partners AG Company Snapshot
Molecular Partners AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Molecular Partners AG with three other miscellaneous service companies in Europe: Formycon AG of Germany (2016 sales of 19.66 million Euro [US$24.10 million] ), Adocia SAS of France (22.49 million Euro [US$27.56 million] of which 100% was Regenerative Medicine), and Molmed S.P.A. which is based in Italy (19.48 million Euro [US$23.88 million] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Molecular Partners AG
  Stock Performance Chart for Molecular Partners AG
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 27.00
(Figures in Swiss Francs)
1 Week 4.7%   13 Weeks 9.3%  
4 Weeks 15.4%   52 Weeks 22.2%  
 
Molecular Partners AG Key Data:
  Ticker: MOLN Country: Switzerland
  Exchanges: ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 23,040,000
(Year Ending Jan 2017).
Employees: 105
  Currency: Swiss Francs Market Cap: 559,353,951
  Fiscal Yr Ends: December Shares Outstanding: 20,716,813
  Share Type: Namenaktie Closely Held Shares: 8,921,529
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.